Oncothermia treatment compatible with intravenous Vitamin C

Intravenous Vitamin C

Vitamin C is a basic nutrient in intracellular oxido-reduction functions. High doses of this nutrient decrease cell proliferation in cancer. In addition, it improves quality of life and chemotherapy-related side effects. Intravenous vitamin C is used in routine oncology clinical practice for its anti-tumour and immune modulating action.
Vitamina C intravenosa
This treatment at high doses has a prooxidant action, indicated in cancers. Vitamin C increases the cytotoxic efficacy of chemotherapy and radiotherapy treatments. It reduces mitochondrial stress. Reduces DNA damage. Reduces ATP depletion. Increases collagen production. Reduces hypoxia, thus reducing tumor viability. Reduces tissue inflammation by modulation of the enzyme kinase. It is immunomodulatory. Vitamin C is a safe and effective treatment for cancer patients undergoing chemotherapy and/or radiotherapy.
Vitamina C intravenosa

References

Riordan HD, et al. Intravenous ascorbic acid: protocol for its application and use. P R Health Sci J. 2003 Sep;22(3):287-90. PMID: 14619456.

Stephenson CM, et al. Phase I clinical trial to evaluate the safety, tolerability, and pharmacokinetics of high-dose intravenous ascorbic acid in patients with advanced cancer. Cancer Chemother Pharmacol. 2013 Jul;72(1):139-46. doi: 10.1007/s00280-013-2179-9. Epub 2013 May 14. PMID: 23670640; PMCID: PMC3691494.

Hoffer LJ, et al. High-dose intravenous vitamin C combined with cytotoxic chemotherapy in patients with advanced cancer: a phase I-II clinical trial. PLoS One. 2015 Apr 7;10(4):e0120228. doi: 10.1371/journal.pone.0120228. PMID: 25848948; PMCID: PMC4388666.

Para más información consulte el link o visite Riordan Clinic.